{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:35:01Z","timestamp":1792715701889,"version":"4.5.0"},"reference-count":61,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0572"],"award-info":[{"award-number":["2024NSFSC0572"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Acute kidney injury (AKI) is a condition with a poor prognosis, exacerbated by the lack of effective therapeutic options and inadequately understood underlying mechanisms. Glycosylation, a post-translational modification of proteins, is essential for maintaining protein stability and function, and its dysregulation leads to protein misfolding and amyloid aggregation. Glycosylation dynamics are implicated in several pathologies, including inflammation, cancer, and AKI, highlighting the therapeutic potential of regulating glycosylation and preventing aggregation in AKI treatment. This study investigates the effect of nafamostat mesylate (NM) on protein glycosylation and amyloid aggregation in vivo. Using optical spectroscopy and other analytical techniques, we demonstrate that NM restores glycosylation levels and inhibits protein aggregation in aristolochic-acid-induced acute kidney injury. The mechanism likely involves enzymatic modulation that corrects hypoglycosylation and prevents amyloid aggregation, promoting proper protein folding and enhancing its stability. These findings suggest that NM may provide a novel therapeutic strategy for AKI and other glycosylation-related diseases, underscoring the potential for early intervention and treatment of these conditions.<\/jats:p>","DOI":"10.3390\/toxins17030145","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:34:43Z","timestamp":1742272483000},"page":"145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury"],"prefix":"10.3390","volume":"17","author":[{"given":"Pei","family":"Xie","sequence":"first","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Drug Targeting and Drug Delivery System Key Laboratory of Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"},{"name":"Co-Construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi & Education Ministry, Shaanxi University of Chinese Medicine, Xianyang 712046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Drug Targeting and Drug Delivery System Key Laboratory of Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Huo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Drug Targeting and Drug Delivery System Key Laboratory of Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Drug Targeting and Drug Delivery System Key Laboratory of Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Drug Targeting and Drug Delivery System Key Laboratory of Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[{"name":"Haisco Pharmaceutical Group Co., Ltd., Chengdu 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongning","family":"Yin","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Drug Targeting and Drug Delivery System Key Laboratory of Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"ref_1","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012). KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl., 2, 19\u201336."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ki.2011.339","article-title":"AKI in the ICU: Definition, epidemiology, risk stratification, and outcomes","volume":"81","author":"Singbartl","year":"2012","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00134-023-07171-z","article-title":"Precision management of acute kidney injury in the intensive care unit: Current state of the art","volume":"49","author":"Stanski","year":"2023","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000536423","article-title":"From rare disorders of kidney tubules to acute renal injury: Progress and Prospective","volume":"10","author":"Li","year":"2024","journal-title":"Kidney Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2024.08.006","article-title":"DUSP5 deficiency suppresses the progression of acute kidney injury by enhancing autophagy through AMPK\/ULK1 pathway","volume":"274","author":"Bai","year":"2024","journal-title":"Transl. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymeth.2015.06.020","article-title":"Kidney diseases and tissue engineering","volume":"99","author":"Moon","year":"2016","journal-title":"Methods"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/CCM.0000000000006328","article-title":"The road to precision medicine for acute kidney injury","volume":"52","author":"Birkelo","year":"2024","journal-title":"Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13613-024-01360-9","article-title":"Biomarkers in acute kidney injury","volume":"14","author":"Ostermann","year":"2024","journal-title":"Ann. Intensive Care"},{"key":"ref_9","first-page":"298","article-title":"Acute kidney injury: A springboard for progression in chronic kidney disease","volume":"5","author":"Venkatachalam","year":"2010","journal-title":"Am. J. Physiol.\u2014Ren. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s00134-017-4788-y","article-title":"A nephrologist should be consulted in all cases of acute kidney injury in the ICU: We are not sure","volume":"43","author":"Schetz","year":"2017","journal-title":"Intensive Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, Z., and Xing, J. (2024). Potential therapeutic applications of circular RNA in acute kidney injury. Biomed. Pharmacother., 174.","DOI":"10.1016\/j.biopha.2024.116502"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jphs.2016.09.005","article-title":"A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity","volume":"132","author":"Kakizoe","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ndt\/gfw158.02","article-title":"SP074Serine Protease Inhibition Attenuates Salt-sensitive hypertension and kidney injury in a rat model of metabolic syndrome","volume":"1","author":"Kakizoe","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10147-023-02326-w","article-title":"Lineage of drug discovery research on fluorinated pyrimidines: Chronicle of the achievements accomplished by Professor Setsuro Fujii","volume":"28","author":"Maehara","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","article-title":"New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin","volume":"661","author":"Fujii","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000215139","article-title":"Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system","volume":"15","author":"Hitomi","year":"1985","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_18","first-page":"1569","article-title":"Effect of postoperative administration of nafamostat mesilate on posthepatectomy liver failure","volume":"24","author":"Lee","year":"2022","journal-title":"Hepato-Pancreato-Biliary"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2016.02.002","article-title":"Nafamostat mesilate protects against acute cerebral ischemia via blood\u2013brain barrier protection","volume":"105","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12974-022-02531-w","article-title":"Delayed administration of nafamostat mesylate inhibits thrombin-mediated blood\u2013spinal cord barrier breakdown during acute spinal cord injury in rats","volume":"19","author":"Zhao","year":"2022","journal-title":"Neuroinflammation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12272-017-0996-9","article-title":"Nafamostat mesilate negatively regulates the metastasis of triple-negative breast cancer cells","volume":"41","author":"Mander","year":"2018","journal-title":"Arch. Pharmacal Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2131\/jts.49.467","article-title":"Nafamostat mesylate sensitizes ovarian cancer cells to carboplatin by promoting the ZNF24-mediated inhibition of WNT2B","volume":"49","author":"Xu","year":"2024","journal-title":"J. Toxicol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.12998\/wjcc.v12.i1.68","article-title":"Efficacy and safety of Nafamostat mesylate in patients with endstage renal failure","volume":"12","author":"Liu","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fukuda, Y., Okada, H., Tomita, H., Suzuki, K., Mori, K., Takada, C., Kawasaki, Y., Fukuda, H., Minamiyama, T., and Nishio, A. (2024). Nafamostat mesylate decreases skin flap necrosis in a mouse model of type 2 diabetes by protecting the endothelial glycocalyx. Biochem. Biophys. Res. Commun., 710.","DOI":"10.1016\/j.bbrc.2024.149843"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.transproceed.2016.03.050","article-title":"Nafamostat Mesilate attenuates ischemia-reperfusion\u2013induced renal injury","volume":"48","author":"Na","year":"2016","journal-title":"Transplant. Proc."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, T., Wang, J., Li, C., Zhang, W., Zhang, L., An, L., Pang, T., Shi, X., and Liao, H. (2014). Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition. Sci. Rep., 4.","DOI":"10.1038\/srep05531"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrneph.2017.129","article-title":"Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases","volume":"13","author":"Cybulsky","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3109\/0886022X.2016.1160724","article-title":"Endoplasmic reticulum stress and its effects on renal tubular cells apoptosis in ischemic acute kidney injury","volume":"38","author":"Xu","year":"2016","journal-title":"Ren. Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e202300162","DOI":"10.1002\/ijch.202300162","article-title":"Protein Glycosylation Patterns Shaped By the IRE1-XBP1s Arm of the Unfolded Protein Response","volume":"64","author":"Chen","year":"2024","journal-title":"Isr. J. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molimm.2021.04.017","article-title":"Protein glycosylation in extracellular vesicles: Structural characterization and biological functions","volume":"135","author":"Santiago","year":"2021","journal-title":"Mol. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ddr.21971","article-title":"Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors","volume":"83","author":"Singh","year":"2022","journal-title":"Drug Dev. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10719-021-10031-x","article-title":"Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression","volume":"38","author":"Muthyalaiah","year":"2021","journal-title":"Glycoconj. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","article-title":"Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions\u2014A review","volume":"206","author":"Zhou","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41581-024-00850-0","article-title":"The role of antibody glycosylation in autoimmune and alloimmune kidney diseases","volume":"20","author":"Beyze","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Novak, J., King, R.G., Yother, J., Renfrow, M.B., and Green, T.J. (2024). O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy. Glycobiology, 34.","DOI":"10.1093\/glycob\/cwae060"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhang, S.-H., Wang, Y., Yang, J., Zhang, D.-D., Wang, Y.-L., Li, S.-H., Pan, Y.-N., Zhang, H.-M., and Sun, Y. (2022). Comparative Analysis of Aristolochic Acids in Aristolochia Medicinal Herbs and Evaluation of Their Toxicities. Toxins, 14.","DOI":"10.3390\/toxins14120879"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, W.-L., Padanilam, B.J., and Kim, J. (2023). The Presence of Testis Determines Aristolochic Acid-Induced Nephrotoxicity in Mice. Toxins, 15.","DOI":"10.3390\/toxins15020118"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.23876\/j.krcp.22.211","article-title":"Overview of aristolochic acid nephropathy: An update","volume":"42","author":"Zhou","year":"2023","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymeth.2015.02.018","article-title":"Using hydroxyl radical footprinting to explore the free energy landscape of protein folding","volume":"89","author":"Calabrese","year":"2015","journal-title":"Methods"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.chempr.2019.07.008","article-title":"Electronic circular dichroism spectroscopy of proteins","volume":"5","author":"Rogers","year":"2019","journal-title":"Chem"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41418-023-01188-z","article-title":"TargetingN-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma","volume":"30","author":"Ma","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbrc.2010.12.074","article-title":"Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1","volume":"404","author":"Sugiyama","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sharma, S., Warsi, M.S., Abidi, M., Tufail, N., Ahmad, R., and Siddiqui, S.A. (2024). Crotonaldehyde induced structural alterations in Low-Density Lipoprotein: Immunogenicity of the modified protein in experimental animals and auto-antibodies generation in various cancers. Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 304.","DOI":"10.1016\/j.saa.2023.123332"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1203\/PDR.0b013e318186e609","article-title":"Zebrafish as a Developmental Model Organism for Pediatric Research","volume":"64","author":"Veldman","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.kint.2016.01.031","article-title":"Little fish, big catch: Zebrafish as a model for kidney disease","volume":"89","author":"Poureetezadi","year":"2016","journal-title":"Kidney Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41581-018-0032-4","article-title":"Pericytes in the renal vasculature: Roles in health and disease","volume":"14","author":"Shaw","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ndt\/gfv190.46","article-title":"Sp234effect of Nafamostat Mesilate as as an Anticoagulant During Continuous Renal Replacement Therapy in Critical Ill Patients","volume":"30","author":"Kim","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kameda, S., Fujii, T., Ikeda, J., Kageyama, A., Takagi, T., Miyayama, N., Asano, K., Endo, A., and Uezono, S. (2023). Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: An observational study. BMC Nephrol, 24.","DOI":"10.1186\/s12882-023-03060-1"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40001-024-01660-7","article-title":"Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: A retrospective single-center study","volume":"29","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wang, X., Giusti, A., Ny, A., and de Witte, P.A. (2020). Nephrotoxic Effects in Zebrafish after Prolonged Exposure to Aristolochic Acid. Toxins, 12.","DOI":"10.3390\/toxins12040217"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/0960327115613844","article-title":"Evaluation of nephrotoxic effects of aristolochic acid on zebrafish (Danio rerio) larvae","volume":"35","author":"Wang","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_52","first-page":"e2126","article-title":"Intraperitoneal Injection into Adult Zebrafish","volume":"42","author":"Kinkel","year":"2010","journal-title":"J. Vis. Exp."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Von Krogh, K., Higgins, J., Saavedra Torres, Y., and Mocho, J.-P. (2021). Screening of Anaesthetics in Adult Zebrafish (Danio rerio) for the Induction of Euthanasia by Overdose. Biology, 10.","DOI":"10.3390\/biology10111133"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.15252\/embr.201643153","article-title":"Euthanizing zebrafish legally in Europe: Are the approved methods of euthanizing zebrafish appropriate to research reality and animal welfare?","volume":"17","author":"Valentim","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_55","first-page":"e2839","article-title":"Dissection of the adult zebrafish kidney","volume":"54","author":"Gerlach","year":"2011","journal-title":"J. Vis. Exp."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Martins, T., Diniz, E., F\u00e9lix, L.M., and Antunes, L. (2018). Evaluation of anaesthetic protocols for laboratory adult zebrafish (Danio rerio). PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197846"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bozkurt, E., and Gul, H.I. (2019). Fluorescence quenching of novel pyrazoline derivative with aniline in different solvents. J. Photochem. Photobiol. A Chem., 383.","DOI":"10.1016\/j.jphotochem.2019.111996"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"107072","DOI":"10.1016\/j.foodhyd.2021.107072","article-title":"Study of the binding mechanism between hydroxytyrosol and bovine serum albumin using multispectral and molecular docking","volume":"122","author":"Lv","year":"2021","journal-title":"Food Hydrocoll."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1021\/acs.accounts.2c00176","article-title":"Solution-State Hydrostatic Pressure Chemistry: Application to Molecular, Supramolecular, Polymer, and Biological Systems","volume":"55","author":"Mizuno","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11095-020-02792-1","article-title":"Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling","volume":"37","author":"Melien","year":"2020","journal-title":"Pharm. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10867-021-09599-0","article-title":"Study of \u03b2-lactam-based drug interaction with albumin protein using optical, sensing, and docking methods","volume":"48","author":"Monirinasab","year":"2022","journal-title":"J. Biol. Phys."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/3\/145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:55:41Z","timestamp":1760028941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/3\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["toxins17030145"],"URL":"https:\/\/doi.org\/10.3390\/toxins17030145","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]}}}